Financhill
Back

Perspective Therapeutics Quote, Financials, Valuation and Earnings

Sell
43

CATX
Perspective Therapeutics

Last Price:
1.36
Seasonality Move:
17.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Perspective Therapeutics Price Quote

$1.36
+0.01 (+0.74%)
(Updated: May 30, 2024 at 12:55 PM ET)

Perspective Therapeutics Key Stats

Sell
43
Perspective Therapeutics (CATX) is a Sell

Day range:
$1.29 - $1.55
52-week range:
$0.21 - $1.91
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.66%

Volume:
11.1M
Avg. volume:
5.9M
1-year change:
164.24%
Market cap:
$840.5M
Revenue:
$0
EPS:
$-0.19

How Much Does Perspective Therapeutics Make?

Data Unavailable

Is Perspective Therapeutics Growing As A Company?

Data Unavailable

Perspective Therapeutics Stock Price Performance

What Is Perspective Therapeutics 52-Week High & Low?

Perspective Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Perspective Therapeutics?

Is Perspective Therapeutics Cash Flow Positive?

  • What Is CATX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$13.3M
  • What Is Perspective Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $167.2M
  • What Is Perspective Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$48.2M

Perspective Therapeutics Return On Invested Capital

Data Unavailable

Perspective Therapeutics Earnings Date & Stock Price

Perspective Therapeutics Competitors

Perspective Therapeutics Dividend Yield

Data Unavailable

Perspective Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% -331.06%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 2.26
Upside from Last Price: 67.41%

Major Shareholders

  • How many CATX shares are owned by institutional investors?
    207.9M CATX shares are owned by institutional investors
  • How many CATX shares are owned by insiders?
    4.4M CATX shares are owned by insiders